Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. reports developments across a Canadian outpatient healthcare platform, digital health software and related technology-enabled services. The company operates a large owned clinic network in Canada and reports recurring updates on patient visits, Canadian Patient Services, primary care and specialty care performance, acquisitions, clinic transformation activity and financial results.
WELL’s news also covers WELLSTAR healthcare technology products, including electronic medical records, AI-powered clinical tools, patient engagement, eReferral and IT managed services. Other recurring themes include HEALWELL AI, CYBERWELL cybersecurity services, virtual cardiology through CardiologyNow, partnerships for remote cardiac monitoring, conference participation and financing capacity for the company’s healthcare operations.
WELL Health (TSX: WELL; OTCQX: WHTCF) will release its Fiscal Fourth Quarter and Year End 2025 results for the period ended December 31, 2025 before market open on Thursday, March 19, 2026. A conference call and webcast to discuss results is scheduled the same day at 1:00 PM ET / 10:00 AM PT, hosted by CEO Hamed Shahbazi and CFO Eva Fong. Investors are asked to dial in 10 minutes early or register to attend the webcast at well.company/events.
WELL Health (OTCQX: WHTCF) reported a record 4.28 million Canadian patient visits in 2025, up 37% YoY and 10% organic. The Canadian network reached 252 clinics and 3,119 providers (27% YoY). Patient satisfaction was high: primary care NPS 80 from 77,500 reviews and Diagnostics Centres ~50,000 Google reviews averaging 4.8–4.9.
WELL added 41 clinics in 2025 (25 in Q4) and reported inorganic growth of 27%, while physician membership grew 34% YoY, highlighting continued clinic expansion and practitioner recruitment.
WELL Health (OTCQX: WHTCF) completed a strategic acquisition and upsized its senior secured credit facility to support clinic growth and e-consult expansion. WELL acquired eight Alberta clinics and a 61% interest in an e-consult platform for approximately $33 million, creating proforma annual revenue of ~ $45 million with ~48% gross margins and >20% operating Adjusted EBITDA margins. The new credit facility increases committed capacity to $400 million (plus $100 million accordion), extends the term to 2030, and leaves >$195 million available capacity to fund a ~ $245 million pipeline of clinic opportunities.
WELL Health Technologies (OTCQX: WHTCF) released a CEO letter dated January 21, 2026 from Founder, Chairman and CEO Hamed Shahbazi outlining the company’s strategic priorities and guiding principles for 2026. The letter frames WELL’s next phase of growth and emphasizes the company’s focus on leveraging technology to support healthcare practitioners and patient outcomes globally. The CEO letter is available on the company website for investors and stakeholders to review.
WELLSTAR Technologies (WHTCF) closed a $62 million Series B Preferred financing on December 8, 2025, issuing 41,352,598 Series B Shares at $1.50 per share to institutional investors including Mawer, Edgepoint and PICTON, plus WELL and management participation.
The Series B Shares match Series A rights, convert into subordinate voting shares on a qualifying liquidity event, accrue dividends starting in 2026, and are redeemable after December 31, 2026. Proceeds are intended for acquisitions, AI-related innovation, organic growth and general corporate purposes. WELLSTAR is targeting a public listing in 2026.
WELL Health Technologies (OTCQX: WHTCF) reported strong Q3 2025 momentum in its Canadian Patient Services business with quarterly revenue > $110 million, a 41% YoY increase. WELL disclosed organic-growth detail: WMC overall +16% (same-clinic +10%, absorption +6%) and WDC overall +16% (same-clinic +16%).
The company reported 92% core digitization progress for clinics in-network >9 months and said it created >45,000 new primary care patient openings across Ontario, Alberta, and Manitoba on June 24, 2025, of which 25,000 were filled by Oct 31, 2025, targeting full fill by end of Q1 2026.
WELL Health (OTCQX: WHTCF) provided a corporate update on its majority-owned WELLSTAR platform on November 13, 2025, highlighting organic growth, acquisitions, and financing.
Key facts: WELLSTAR Q3 revenue was $18.3M (+67% YoY) with organic growth +26%. ARR grew 63% YoY to $66.0M as of September 30, 2025, and a new provincial OceanMD eReferral contract immediately uplifted ARR by 16%. WELLSTAR closed a $62M Series B equity financing and signed three November M&A deals, including Mutuo (AutoScribe) and two billing assets expected to add ~$4M annualized revenue with >20% margins.
WELL Health Technologies (OTCQX: WHTCF) reported record Q3-2025 results: $364.6M revenue (+56% YoY) and $59.9M Adjusted EBITDA (+296% YoY) with a 16.4% Adjusted EBITDA margin (up 990 bps). Excluding Circle Medical deferred revenue adjustments (“CM Deferrals”), Q3 revenue was $347.0M and Adjusted EBITDA $42.3M. Nine-months: >$1.0B revenue and $137M Adjusted EBITDA. Key drivers: organic growth, acquisitions (12 Canadian clinical deals YTD adding $67.0M revenue), HEALWELL consolidation, and WELLSTAR growth. WELLSTAR secured a $62M Series B financing at a ~C$1.50 share price, implying ~$535M post-money valuation. Management reaffirmed 2025 guidance: $1.40–1.45B revenue and $190–210M Adjusted EBITDA.
WELLSTAR Technologies (OTCQX: WHTCF) agreed to a C$62 million Series B preferred share financing at C$1.50 per Series B Share, supported by Mawer, Edgepoint and PICTON and expected to close early December 2025, subject to closing conditions.
The round follows a C$50.4 million Series A at C$1.00 per share in December 2024. On closing, WELLSTAR will issue C$59 million to institutional investors and ~C$3 million to management. Series B Shares convert to subordinate voting shares on a qualifying IPO/RTO or liquidity event and will accrue dividends starting in 2026; they are redeemable at holders' option after December 31, 2026. WELL intends to retain majority economic and voting interest; proceeds target acquisitions, AI innovation and growth.
WELL Health Technologies (OTCQX: WHTCF) will release its Fiscal Q3 2025 results for the period ended September 30, 2025 before market open on Thursday, November 6, 2025. The company will host a conference call and simultaneous webcast the same day at 1:00 PM ET / 10:00 AM PT featuring Hamed Shahbazi, Chairman and CEO, and Eva Fong, Chief Financial Officer.
Investors are asked to dial in 10 minutes early. International and North American toll numbers are provided, and webcast registration or access details are available at well.company/events.